398 related articles for article (PubMed ID: 1281075)
21. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
Pigott TA; Seay SM
J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636
[TBL] [Abstract][Full Text] [Related]
22. Sertraline 50 mg daily: the optimal dose in the treatment of depression.
Preskorn SH; Lane RM
Int Clin Psychopharmacol; 1995 Sep; 10(3):129-41. PubMed ID: 8675965
[TBL] [Abstract][Full Text] [Related]
23. Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder.
Barr LC; Goodman WK; Anand A; McDougle CJ; Price LH
Am J Psychiatry; 1997 Sep; 154(9):1293-5. PubMed ID: 9286191
[TBL] [Abstract][Full Text] [Related]
24. Will pindolol augment the response to a serotonin reuptake inhibitor in obsessive-compulsive disorder?
Koran LM; Mueller K; Maloney A
J Clin Psychopharmacol; 1996 Jun; 16(3):253-4. PubMed ID: 8784659
[No Abstract] [Full Text] [Related]
25. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.
Sánchez C; Hyttel J
Cell Mol Neurobiol; 1999 Aug; 19(4):467-89. PubMed ID: 10379421
[TBL] [Abstract][Full Text] [Related]
26. The pharmacotherapy of obsessive-compulsive disorder.
McDougle CJ; Goodman WK; Price LH
Pharmacopsychiatry; 1993 May; 26 Suppl 1():24-9. PubMed ID: 8378419
[TBL] [Abstract][Full Text] [Related]
27. Panic attacks precipitated by sertraline.
Zinner SH
Am J Psychiatry; 1994 Jan; 151(1):147-8. PubMed ID: 8267115
[No Abstract] [Full Text] [Related]
28. Selective serotonin reuptake inhibitors: pharmacologic profiles and potential therapeutic distinctions.
Finley PR
Ann Pharmacother; 1994 Dec; 28(12):1359-69. PubMed ID: 7696728
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis.
Greist JH; Jefferson JW; Kobak KA; Katzelnick DJ; Serlin RC
Arch Gen Psychiatry; 1995 Jan; 52(1):53-60. PubMed ID: 7811162
[TBL] [Abstract][Full Text] [Related]
30. Sertraline: a new antidepressant.
Doogan DP; Caillard V
J Clin Psychiatry; 1988 Aug; 49 Suppl():46-51. PubMed ID: 2842321
[TBL] [Abstract][Full Text] [Related]
31. [Response to sertraline in adolescents with obsessive-compulsive disorder].
RodrÃguez-Ramos P; Mardomingo Sanz MJ
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(1):17-21. PubMed ID: 9549132
[TBL] [Abstract][Full Text] [Related]
32. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.
Rosenbaum JF; Fava M; Hoog SL; Ascroft RC; Krebs WB
Biol Psychiatry; 1998 Jul; 44(2):77-87. PubMed ID: 9646889
[TBL] [Abstract][Full Text] [Related]
33. Spotlight on sertraline in the management of major depressive disorder in elderly patients.
Muijsers RB; Plosker GL; Noble S
CNS Drugs; 2002; 16(11):789-94. PubMed ID: 12383038
[TBL] [Abstract][Full Text] [Related]
34. Striking a balance between safety and efficacy: experience with the SSRI sertraline.
Casey DE
Int Clin Psychopharmacol; 1994 Jun; 9 Suppl 3():5-12. PubMed ID: 7963450
[TBL] [Abstract][Full Text] [Related]
35. Sertraline: a review of its use in the management of major depressive disorder in elderly patients.
Muijsers RB; Plosker GL; Noble S
Drugs Aging; 2002; 19(5):377-92. PubMed ID: 12093324
[TBL] [Abstract][Full Text] [Related]
36. Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression.
Miller HL; Delgado PL; Salomon RM; Berman R; Krystal JH; Heninger GR; Charney DS
Arch Gen Psychiatry; 1996 Feb; 53(2):117-28. PubMed ID: 8629887
[TBL] [Abstract][Full Text] [Related]
37. Medication optimization during clozapine treatment.
Suppes T; Rush AJ
J Clin Psychiatry; 1996 Jul; 57(7):307-8. PubMed ID: 8666574
[No Abstract] [Full Text] [Related]
38. Targeted pharmacotherapy in depression management: comparative pharmacokinetics of fluoxetine, paroxetine and sertraline.
Preskorn S
Int Clin Psychopharmacol; 1994 Jun; 9 Suppl 3():13-9. PubMed ID: 7963446
[TBL] [Abstract][Full Text] [Related]
39. Sertraline and obsessive compulsive disorder: new indication. Limited assessment.
Prescrire Int; 2000 Aug; 9(48):112-3. PubMed ID: 11067720
[TBL] [Abstract][Full Text] [Related]
40. Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder.
Greist J; Chouinard G; DuBoff E; Halaris A; Kim SW; Koran L; Liebowitz M; Lydiard RB; Rasmussen S; White K
Arch Gen Psychiatry; 1995 Apr; 52(4):289-95. PubMed ID: 7702445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
